Siemens Healthineers AG
Company Profile
Business description
Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (55% of sales in fiscal 2024) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (17% of sales) offers radiotherapy and other oncology solutions. The portfolio of the diagnostics segment (20%) includes in vitro diagnostics products offered to providers and point-of-care diagnostics. The advanced therapies segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. Americas represents 42% of total sales, Europe, Middle East, and Africa 33%, and Asia-Pacific including China the remainder.
Contact
Siemensstrasse 3
ForchheimBY91301
DEUT: +49 9131843385
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
30 September 2025
Employees
73,500
Siemens Healthineers AG News & Analysis
stocks
3 overvalued ASX stocks with cheaper alternatives
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,080.70 | 39.80 | -0.44% |
CAC 40 | 7,763.47 | 28.63 | 0.37% |
DAX 40 | 23,718.84 | 88.29 | -0.37% |
Dow JONES (US) | 45,514.95 | 114.09 | 0.25% |
FTSE 100 | 9,241.62 | 20.18 | 0.22% |
HKSE | 25,938.13 | 304.22 | 1.19% |
NASDAQ | 21,798.70 | 98.31 | 0.45% |
Nikkei 225 | 43,459.29 | 184.52 | -0.42% |
NZX 50 Index | 13,253.73 | 27.41 | -0.21% |
S&P 500 | 6,495.15 | 13.65 | 0.21% |
S&P/ASX 200 | 8,803.50 | 37.40 | -0.42% |
SSE Composite Index | 3,807.29 | 19.55 | -0.51% |